YONKERS, N.Y., Sept. 06, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody ...
Expert Rev Anti Infect Ther. 2009;7(8):967-980. Nafcillin is considered the intravenous treatment of choice for MSSA; however, many other intravenous agents such as cephalosporins, β-lactams and ...
A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal ...
During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical ...
Patients staying in hospital rooms with multiple beds are at an increased risk — up to ninefold higher — for Staphylococcus ...
NEW YORK (Reuters Health) - Aspirin therapy may protect dialysis patients from infection with the virulent, potentially life-threatening bug Staphylococcus aureus. Based on lab studies showing that ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window An early switch to oral antibiotics in patients hospitalized ...
A Bacillus subtilis probiotic demonstrated the ability to wipe out most Staphylococcus aureus colonization without altering the gut microbiome, a placebo-controlled phase II study conducted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback